Clinical trial · Observational
Adaptive and Maladaptive Emotions in Patients With Cancer: Identification of Indicators
NCT05062447CI-TRIAL-00083562EMOCAterminatedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Why stopped (as posted): No extention of the deadline was possible anymore.
Summary
Brief summary (as posted)
Primary Objective: To identify indicators distinguishing between adaptive and maladaptive emotions in patients with cancer.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Adaptation, Emotional | — | UNRESOLVED | — |
Interventions
Interventions (0)
Data not yet available
No intervention recorded.
Design
Arms and outcomes
Arms (4)
- label
- Adaptive emotions, non-metastatic disease
- description
- Participants who are categorized as having 'adaptive emotions' and have a non-metastatic disease
- label
- Adaptive emotions, metastatic disease
- description
- Participants who are categorized as having 'adaptive emotions' and have a metastatic disease
- label
- maladaptive emotions, non-metastatic disease
- description
- Participants who are categorized as having 'maladaptive emotions' and have a non-metastatic disease
- label
- maladaptive emotions, metastatic disease
- description
- Participants who are categorized as having 'maladaptive emotions' and have a metastatic disease
Primary outcomes (8)
- measure
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * diagnosis of a solid malignancy cancer, (i) non-metastatic disease or (ii) metastatic disease; * between 3 and 7 months after start of treatment with (neo)adjuvant or 1st line chemotherapy or with (neo)adjuvant or 1st line immunotherapy; * life expectancy of more than 3 months. Exclusion Criteria: * age \< 18; * insufficient command of the Dutch language; * severe psychopathology, other than mood or anxiety disorder (e.g. lifetime history of bipolar disorder, schizophrenia, MDD (Major Depressive Disorder) with psychotic features, schizoaffective disorders); * severe cognitive impairments (e.g. dementia); * patients with a (indication of) brain tumor or -metastases; * a history of severe drug or alcohol abuse within past 6 months; * not competent in the use of a mobile phone * no informed consent.
References
Publications (0)
Data not yet available
No reference posted for this study.